These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 17350337

  • 1. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
    Webster-Gandy JD, How C, Harrold K.
    Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
    [Abstract] [Full Text] [Related]

  • 2. The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy.
    Janusch M, Fischer M, Marsch WCh, Holzhausen HJ, Kegel T, Helmbold P.
    Eur J Dermatol; 2006 Jul; 16(5):494-9. PubMed ID: 17101468
    [Abstract] [Full Text] [Related]

  • 3. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S, Langer SW.
    Ugeskr Laeger; 2003 Aug 11; 165(33):3161-2. PubMed ID: 12968412
    [Abstract] [Full Text] [Related]

  • 4. Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
    Tanyi JL, Smith JA, Ramos L, Parker CL, Munsell MF, Wolf JK.
    Gynecol Oncol; 2009 Aug 11; 114(2):219-24. PubMed ID: 19446868
    [Abstract] [Full Text] [Related]

  • 5. Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).
    Lassere Y, Hoff P.
    Eur J Oncol Nurs; 2004 Aug 11; 8 Suppl 1():S31-40. PubMed ID: 15341880
    [Abstract] [Full Text] [Related]

  • 6. Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin.
    Gordinier ME, Dizon DS, Fleming EL, Weitzen S, Schwartz J, Parker LP, Granai CO.
    Gynecol Oncol; 2006 Oct 11; 103(1):72-4. PubMed ID: 16494932
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.
    Nagore E, Insa A, Sanmartín O.
    Am J Clin Dermatol; 2000 Oct 11; 1(4):225-34. PubMed ID: 11702367
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy-induced palmer planter erythrodysesthesia.
    Bhasin S, Sunita, Gupta DK, Kataria SP, Saluja S, Sharma M.
    J Assoc Physicians India; 2005 Feb 11; 53():155-6. PubMed ID: 15847041
    [Abstract] [Full Text] [Related]

  • 10. Grade 3 liposomal-doxorubicin-induced skin toxicity in a patient following complete resolution of moderately severe sunburn.
    Markman M, Kulp B, Peterson G.
    Gynecol Oncol; 2004 Aug 11; 94(2):578-80. PubMed ID: 15297208
    [Abstract] [Full Text] [Related]

  • 11. [Main treatment and preventive measures for hand-foot syndrome, a dermatologic side effect of cancer therapy].
    Bartal A, Mátrai Z, Szûcs A, Liszkay G.
    Magy Onkol; 2011 Jun 11; 55(2):91-8. PubMed ID: 21655474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicin.
    Miolo G, Baldo P, Bidoli E, Lombardi D, Scalone S, Sorio R, Veronesi A.
    Tumori; 2009 Jun 11; 95(6):687-90. PubMed ID: 20210230
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].
    Hueso L, Sanmartín O, Nagore E, Botella-Estrada R, Requena C, Llombart B, Serra-Guillén C, Alfaro-Rubio A, Guillén C.
    Actas Dermosifiliogr; 2008 May 11; 99(4):281-90. PubMed ID: 18394404
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.
    Drake RD, Lin WM, King M, Farrar D, Miller DS, Coleman RL.
    Gynecol Oncol; 2004 Aug 11; 94(2):320-4. PubMed ID: 15297168
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.